AzTrials
AzTrials

DysphagiaNCT05108896

Aspiration in Acute Respiratory Failure Survivors 2

A study testing 3-Screenings Protocol, FEES and Tracheal Ultrasound in people with Dysphagia and Aspiration, run by University of Colorado, Denver at 5 sites in United States.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Dysphagia, Aspiration
What is being tested?
3-Screenings Protocol, FEES and Tracheal Ultrasound
Could I receive a placebo?
No, everyone receives an active treatment
How many people
855 participants
Where
5 sitesUnited States
Study dates
15 Dec 2021to 15 Dec 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Admission to an ICU.
  • Mechanical ventilation with an endotracheal tube for greater than 48 hours.

Who cannot join

  • Likely persistent contraindications to enteral/oral nutrition administration.
  • Pre-existing history of dysphagia or aspiration.
  • Pre-existing or acute primary central or peripheral neuromuscular disorder.
  • Presence of a chronic tracheostomy (present prior to ICU admission).
  • Pre-existing head and neck cancer or surgery.
  • Coagulopathy resulting in uncontrolled nasal or pharyngeal bleeding.
Show all 10Show fewer
  • Delirium for more than 96 hours after extubation as assessed by Confusion Assessment Method (CAM-ICU).
  • Extubated for greater than 96 hours.
  • Inability to obtain informed consent from patient or an appropriate surrogate.
  • Age < 18 years.

Trial locations and contacts

5 sites in 1 country.

Jeff McKeehan, RN,MSN contact

3037246080

jeffrey.mckeehan@cuanschutz.edu

5 sites in 1 country

United States5 sites, 5 recruiting
  • University of Colorado

    Aurora, Colorado, 80045

    Anna Matheson, RN, BSN, 303-724-6377, anna.matheson@cuanschutz.edu

    Jeffrey McKeehan, RN, MSN, 3037246080, Jeffrey.McKeehan@cuanschutz.edu

    Recruiting
  • Tufts Medical Center

    Boston, Massachusetts, 02111

    Nicholas Hill, MD, nicholas.hill@tuftsmedicine.org

    Nicholas Hill, MD

    Recruiting
  • Boston University

    Boston, Massachusetts, 02118

    Gintas Krisciunas, MPH, MS, Gintas.Krisciunas@bmc.org

    Gintas Krisciunas, MPH, MS

    Recruiting
  • Yale University

    New Haven, Connecticut, 06519

    Jonathan Siner, MD, Jonathan.Siner@yale.edu

    Jonathan Siner, MD

    Recruiting
  • Stanford Univerity

    Stanford, California, 94305

    Joseph Levitt, MD, MS, JLevitt@stanford.edu

    Joseph Levitt, MD, MS

    Recruiting

Other trials in United States

About this study

Official title: Aspiration in Acute Respiratory Failure Survivors

The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe.

Read the detailed description

The purpose of this study is to learn more about problems with swallowing that could develop in patients who are very sick and need a machine to help them breathe. Patients are asked to be in this study because they had problems breathing on their own and therefore needed the help of a machine called a ventilator. In order for this ventilator to push air into the lungs, patients need a tube placed in the throat called an endotracheal tube. The process of placing this endotracheal tube was called intubation. The tube has now been removed, which is a process called extubation. Sometimes, people who have had endotracheal tubes can have difficulty swallowing food and liquids for a period of time. This disease is called post-extubation dysphagia (PED). PED is a serious condition and may result in food or liquid going from the mouth into the lungs. This could cause further lung problems. Given this risk, doctors sometimes suggest that patients with PED either avoid eating or drinking, or get a feeding tube. Currently, nobody knows how often patients develop PED, why they develop it, or the best method to detect it. Standard care involves clinicians making educated guesses. This study looks to determine if watching the patient swallow, both with and without a small camera, is an accurate method for detecting PED.

Being tested
3-Screenings Protocol, FEES, Tracheal Ultrasound
Medical subject headings
Deglutition Disorders

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • 3-Screenings ProtocolDiagnostic test

    Also called Modified bedside swallow exam (BSE), Three Screening Tests

    The 3-Screenings Protocol is a modified bedside swallow exam (BSE) consisting of a study developed five-item decision tree algorithm including voice quality assessment and a 2-ounce water consistency assessment, the Yale Swallow Test, with a scored 3-ounce Water Swallow Test (3-WST), and the Toronto Bedside Swallowing Screening Test (TOR-BSST).

  • FEESDiagnostic test

    Also called Fiberoptic Endoscopic Evaluation of Swallowing

    A thin, flexible endoscope designed for assessment of laryngeal structures is passed through the nose to the oropharynx, visualizing the laryngeal structures, and the base of tongue and the pharynx. If needed 4% topical lidocaine and/or oxymetazoline (Afrin) will be administered. Swallowing will then be evaluated directly with six food boluses of 5 ml each. All patients will be allowed to swallow spontaneously without a verbal command to swallow. Video of the examinations will be recorded and presence of dysphagia will be designated independently by 3 different observers (one pulmonary physician and two speech language pathologists (SLPs)). This procedure will take 5-10 minutes. The camera will then be removed.

  • Tracheal UltrasoundDiagnostic test

    Ultrasound imaging of the trachea, measuring tracheal diameter and endotracheal tube (ETT) size ratio within 72 hours prior to extubation

Study groups in NCT05108896
Study groupRoleWhat they receive
Aspiration in Acute Respiratory Failure SurvivorsOtherAll participants will receive a tracheal ultrasound within 72 hours prior to extubation, collection of demographic and hospital clinical information, administration of 3 screening tests (study defined algorithm test, 3-ounce water swallow test, TOR-BSST) addressing swallowing function within 24 hours post-extubation, and a fiberoptic endoscopic examination of swallowing (FEES) exam.
Receives: Diagnostic Test: 3-Screenings Protocol; Diagnostic Test: FEES; Diagnostic Test: Tracheal Ultrasound

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percentage of participants experiencing aspiration on the FEES with any of the feeding consistencies

    Aspiration (PAS score of ≥6) on the FEES with any of the feeding consistencies. A PAS score of ≥ 6 includes patients with both silent and non-silent aspiration. Using a PAS cutoff score of ≥6 on FEES, patients will be stratified by aspiration on any of the five consistencies.

    Measured: from extubation day 1 through hospital discharge, expected to be within 28 days

Secondary outcomes (5)
  1. Percentage of participants experiencing non-silent aspiration

    We will stratify patients who aspirate into non-silent (PA = 6- 7) and silent (PAS=8) aspiration, and also determine maximum PAS scores across bolus and consistency types. Aspiration (PAS score of ≥6) on the FEES with any of the feeding consistencies. A PAS score of ≥ 6 includes patients with both silent and non-silent aspiration. Using a PAS cutoff score of ≥6 on FEES, patients will be stratified by aspiration on any of the five consistencies. We will also determine the maximum PAS scores across bolus and consistency types.

    Measured: from extubation day 1 through hospital discharge, expected to be within 28 days

  2. Percentage of participants experiencing silent aspiration

    We will stratify patients who aspirate into non-silent (PA = 6- 7) and silent (PAS=8) aspiration, and also determine maximum PAS scores across bolus and consistency types. Aspiration (PAS score of ≥6) on the FEES with any of the feeding consistencies. A PAS score of ≥ 6 includes patients with both silent and non-silent aspiration. Using a PAS cutoff score of ≥6 on FEES, patients will be stratified by aspiration on any of the five consistencies. We will also determine the maximum PAS scores across bolus and consistency types.

    Measured: from extubation day 1 through hospital discharge, expected to be within 28 days

  3. Percentage of participants experiencing post-extubation clinical laryngeal edema

    We will define laryngeal edema as upper-airway obstruction within 24 hours after extubation. Minor laryngeal edema will be defined as stridor associated with a respiratory distress defined as a prolonged inspiratory phase and the presence of edema on FEES examination. Major laryngeal edema will defined as severe respiratory distress needing tracheal reintubation secondary to upper-airway obstruction that was visualized during the FEES examination

    Measured: Within 24 hours after extubation

  4. Duration of mechanical ventilation

    We will also collect the overall length of mechanical ventilation in days

    Measured: from intubation and receipt of mechanical ventilation through extubation, expected to be within 2-14 days on average

  5. Duration required for liberation from mechanical ventilation

    We will also collect the overall length of the liberation process from mechanical ventilation in days

    Measured: from intubation and receipt of mechanical ventilation through extubation, expected to be within 2-14 days on average

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted5 Nov 2021
  2. Study start15 Dec 2021
  3. Primary completion15 Dec 2025 (estimated)
  4. Study completion15 Dec 2025 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Diagnosis
Allocation
Not applicable
Intervention model
Single group
Model description
Multi-center prospective single cohort study
Masking
None (open label)
Enrolment
855 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05108896
Sponsor's protocol ID
21-3873
Other IDs
R01NR019989
Status last verified
Oct 2024
First submitted
25 Oct 2021
Last updated
8 Oct 2024
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Kempker JA, Abril MK, Chen Y, Kramer MR, Waller LA, Martin GS. The Epidemiology of Respiratory Failure in the United States 2002-2017: A Serial Cross-Sectional Study. Crit Care Explor. 2020 Jun 10;2(6):e0128. doi: 10.1097/CCE.0000000000000128. eCollection 2020 Jun.

    PubMed 32695994
  • Wunsch H, Linde-Zwirble WT, Angus DC, Hartman ME, Milbrandt EB, Kahn JM. The epidemiology of mechanical ventilation use in the United States. Crit Care Med. 2010 Oct;38(10):1947-53. doi: 10.1097/CCM.0b013e3181ef4460.

    PubMed 20639743
  • Barker J, Martino R, Reichardt B, Hickey EJ, Ralph-Edwards A. Incidence and impact of dysphagia in patients receiving prolonged endotracheal intubation after cardiac surgery. Can J Surg. 2009 Apr;52(2):119-24.

    PubMed 19399206
  • El Solh A, Okada M, Bhat A, Pietrantoni C. Swallowing disorders post orotracheal intubation in the elderly. Intensive Care Med. 2003 Sep;29(9):1451-5. doi: 10.1007/s00134-003-1870-4. Epub 2003 Aug 2.

    PubMed 12904855
  • Macht M, White SD, Moss M. Swallowing dysfunction after critical illness. Chest. 2014 Dec;146(6):1681-1689. doi: 10.1378/chest.14-1133.

    PubMed 25451355
  • Macht M, Wimbish T, Bodine C, Moss M. ICU-acquired swallowing disorders. Crit Care Med. 2013 Oct;41(10):2396-405. doi: 10.1097/CCM.0b013e31829caf33.

    PubMed 23939361
  • Skoretz SA, Flowers HL, Martino R. The incidence of dysphagia following endotracheal intubation: a systematic review. Chest. 2010 Mar;137(3):665-73. doi: 10.1378/chest.09-1823.

    PubMed 20202948
  • Moss M, White SD, Warner H, Dvorkin D, Fink D, Gomez-Taborda S, Higgins C, Krisciunas GP, Levitt JE, McKeehan J, McNally E, Rubio A, Scheel R, Siner JM, Vojnik R, Langmore SE. Development of an Accurate Bedside Swallowing Evaluation Decision Tree Algorithm for Detecting Aspiration in Acute Respiratory Failure Survivors. Chest. 2020 Nov;158(5):1923-1933. doi: 10.1016/j.chest.2020.07.051. Epub 2020 Jul 25.

    PubMed 32721404
  • Borders JC, Fink D, Levitt JE, McKeehan J, McNally E, Rubio A, Scheel R, Siner JM, Taborda SG, Vojnik R, Warner H, White SD, Langmore SE, Moss M, Krisciunas GP. Relationship Between Laryngeal Sensation, Length of Intubation, and Aspiration in Patients with Acute Respiratory Failure. Dysphagia. 2019 Aug;34(4):521-528. doi: 10.1007/s00455-019-09980-1. Epub 2019 Jan 29.

    PubMed 30694412
  • Krisciunas GP, Langmore SE, Gomez-Taborda S, Fink D, Levitt JE, McKeehan J, McNally E, Scheel R, Rubio AC, Siner JM, Vojnik R, Warner H, White SD, Moss M. The Association Between Endotracheal Tube Size and Aspiration (During Flexible Endoscopic Evaluation of Swallowing) in Acute Respiratory Failure Survivors. Crit Care Med. 2020 Nov;48(11):1604-1611. doi: 10.1097/CCM.0000000000004554.

    PubMed 32804785
  • DePippo KL, Holas MA, Reding MJ. Validation of the 3-oz water swallow test for aspiration following stroke. Arch Neurol. 1992 Dec;49(12):1259-61. doi: 10.1001/archneur.1992.00530360057018.

    PubMed 1449405
  • Martino R, Silver F, Teasell R, Bayley M, Nicholson G, Streiner DL, Diamant NE. The Toronto Bedside Swallowing Screening Test (TOR-BSST): development and validation of a dysphagia screening tool for patients with stroke. Stroke. 2009 Feb;40(2):555-61. doi: 10.1161/STROKEAHA.107.510370. Epub 2008 Dec 12.

    PubMed 19074483
  • Suiter DM, Leder SB. Clinical utility of the 3-ounce water swallow test. Dysphagia. 2008 Sep;23(3):244-50. doi: 10.1007/s00455-007-9127-y. Epub 2007 Dec 4.

    PubMed 18058175
  • Suiter DM, Sloggy J, Leder SB. Validation of the Yale Swallow Protocol: a prospective double-blinded videofluoroscopic study. Dysphagia. 2014 Apr;29(2):199-203. doi: 10.1007/s00455-013-9488-3. Epub 2013 Sep 12.

    PubMed 24026519
  • Langmore SE. Role of flexible laryngoscopy for evaluating aspiration. Ann Otol Rhinol Laryngol. 1998 May;107(5 Pt 1):446. doi: 10.1177/000348949810700516. No abstract available.

    PubMed 9596227

Questions about this trial

What is this clinical trial studying?

A study testing 3-Screenings Protocol, FEES and Tracheal Ultrasound in people with Dysphagia and Aspiration, run by University of Colorado, Denver at 5 sites in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 10 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 8 Oct 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 5 sites in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Contact Jeff McKeehan, RN,MSN (3037246080, jeffrey.mckeehan@cuanschutz.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percentage of participants experiencing aspiration on the FEES with any of the feeding consistencies (time frame: from extubation day 1 through hospital discharge, expected to be within 28 days). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05108896, which also lists 112 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 Oct 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in